ExosiRNA−OPN was found to inhibit TGF-β1 signaling by reducing HMGB1, then to attenuate the progression of liver fibrosis in a CCl4-induced mouse model of liver fibrosis [157]. Here, HMGB1 is linked to Hepatic fibrosis.